| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Anaesthesia, Bir Hospital, Kathmandu, Nepal.
Address correspondence to: Dr. B. M. Shrestha, Senior Consultant Anaesthetist, Department of Anaesthesia, Kathmandu Medical College Teaching Hospital, P.O. Box 7964, Kathmandu, Nepal. Phone: 977 1 421 150; Fax: 977 1 247 032; E-mail: bisharadshrestha{at}hotmail.com
| Abstract |
|---|
|
|
|---|
Methods: We conducted a retrospective analysis of a sample of 378 cases anesthetized at the Bir Hospital and at a private hospital in Kathmandu from April through October 1999. The Bain circuit or its modification was used in adults, and Bain or Ayre's T piece in children. High flows from the oxygen concentrator used with the Bain and Ayre's T-circuits were reduced to 2 Lmin1, delivered through the halothane vaporizer, supplemented by room air in the modified Bain circuit. Positive pressure ventilation was provided with an Ambubag, Oxford Inflating Bellows or Penlon Manley Multivent Ventilator. Blood pressure, electrocardiogram, FIO2 and SpO2 were monitored in all cases.
Results: Surgery included urologic, general surgery, obstetrics and gynecological procedures, neurosurgery and closed mitral valvotomy. Age ranged from six months to 78 yr. The anesthetic time lasted from 45 min to 12 hr. The FIO2 ranged from 0.5 to 0.6 in the Bain and Ayre's T circuits, and from 0.34 to 0.40 in the modified Bain circuit with a flow of oxygen of 2 Lmin1 from the concentrator.
Conclusion: With regular maintenance and servicing done locally, the oxygen concentrator can be used safely in adults and children. Use of the oxygen concentrator is a suitable alternative to oxygen cylinders in the developing world.
| Introduction |
|---|
|
|
|---|
In order to solve the problem, the use of oxygen concentrators was introduced in 1985. However, the first concentrator delivered a low percentage of O2 and broke down within six months.b
In 1993, while conducting a trial of the Penlon Manley Multivent Ventilator (PMMV) we received a DeVilbiss oxygen concentrator1 which could supply O2 supplemented with compressed air to the ventilator for use in anesthesia.c Since then, we have used an oxygen concentrator as a source of O2 in anesthesia for draw over or plenum systems or in a modified Bain system.2 We have used this oxygen concentrator in a wide range of surgical cases including neurologic and cardiothoracic operations. We have used it in the central hospitals and in surgical camps at remote mountain sitesdwith satisfactory results.
The concentrator is still functioning and reliable, as it is still delivering more than 85% oxygen at flow rates of 5 Lmin1. Our experience suggests that this should be the prime source of oxygen supply to the operating rooms,3 wards and for domiciliary use in our country keeping O2 cylinders in reserve if needed.
| Materials and methods |
|---|
|
|
|---|
In both centres, a DeVilbiss oxygen concentrator, halothane vaporizer (Mark 2 or later model) and PMMV were available. Ambubag or Oxford Inflating Bellows (OIB) were also available in case of emergency or failure of the PMMV. All patients needing general anesthesia were anesthetized with the Bain system using oxygen and halothane or modified Bain system using O2, air and halothane (Figure 1
).
|
|
| Results |
|---|
|
|
|---|
|
| Discussion |
|---|
|
|
|---|
Oxygen concentrators have been available in some of the central hospitals in Nepal since 1985. These were used in wards for patients needing O2. Due to lack of reliable maintenance service most of the older concentrators broke down within a year, and even the percentage of O2 supplied by the concentrators was not satisfactory.b Spare parts were not available in the country. Thus, doctors and nurses were not keen on using these concentrators. At present, very few functioning units are available in central and peripheral hospitals in Nepal.
The Patan Hospital, another hospital in the Kathmandu valley, has used the concentrator in the operating room since 1985 for O2 supplementation in a draw-over anesthetic system. Our personal experience with an oxygen concentrator (DeVilbiss) in anesthesia dates from 1993 when we first received it, supplied with the trial model of the PMMV. We started using the oxygen concentrator in anesthesia, and until now we have used it in over 4,000 operative cases including cardiothoracic and neurosurgical anesthesia without any problems.
How the oxygen concentrator works7ef
Atmospheric air consists of approximately 79% nitrogen (N) and 21% O2. A simple method of on site production of O2 from air became possible nearly 25 years back by using membrane or zeolite molecular sieve technology. The membrane type can only produce 40% pure O2, whereas the molecular sieve technology can produce up to 95% pure O2.
Room air is drawn into the oxygen concentrator through a series of filters to remove dust and bacteria. The concentrator contains two columns of the zeolite molecular sieve in a canister. The sieve adsorbs N from the air as it is forced through under pressure. The sieve allows O2 to pass through along with the 1% argon present in the air. The two columns function alternatively so that there is a continuous supply of O2. Synthetic zeolite is used for the production of oxygen. It consists of a rigid framework of silica and aluminium with an extra cation of calcium or sodium to make up the missing positive charge in the structure.
The concentrator needs 300 watts AC power. Adsorption efficiency is enhanced by a modest increase in operating pressure and takes place at a pressure of 20 PSI (140KPa). After about 20 sec the supply of compressed air is automatically diverted to the second canister where the process is repeated enabling uninterrupted output of O2. While the pressure in the second canister is at 20 PSI, the pressure in the first canister is reduced to zero. This allows discharging most of the adsorbed N from the zeolite to the atmosphere. The zeolite is then regenerated and ready for the next cycle. As the second column approaches saturation, the process is reversed. By alternating the pressure in the two canisters a constant supply of O2 is produced while the zeolite is continually being regenerated. Individual units have an output of up to 5 Lmin1 with an O2 concentration of up to 95%. Higher flows result in a loss of concentration, and most machines are flow-limited to prevent this from occurring. The gas emerging from the columns normally is composed of 95% O2 and 5% argon. This gas passes into a small reservoir chamber, and then through a flow control system to the patient.
The life of the zeolite crystal can be expected to be at least 20,000 hr, which in most situations would give about ten years of use. Routine maintenance consists merely of changing the filters at regular intervals as directed by the manufacturer. This can be achieved easily, using skills available locally. If recommendations are followed, the unit requires no other attention and will continue to function for many years (Figure 2
).
|
In a developing country like ours, one may anticipate problems associated with the effects of high relative humidity during the rainy season, high dust content in the air during the dry season, and high altitude. In our experience, water infiltration into the anesthetic ventilator and machine is minimal and has not affected the function of these machines till now. The three standard filters at the air intake have proven sufficient to keep dust out of the concentrator. Altitude has no effect on the concentration of O2 produced. Hence, the overall use of the oxygen concentrator has been reliable and satisfactory.
| Conclusion |
|---|
|
|
|---|
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
b Swar BB. Oxygen concentrators in Nepal, how useful and reliable? 5t h Symposium SAN Souvenir May 15-16, 1992: 33-5. ![]()
c Shrestha BM, Amatya R, Basnyat NB, Singh BB, Lekhah BD, Gurung A. The Penlon Manley Multivent in Nepal. World Anaesthesia Newsletter 1995; 13: 10-1. ![]()
d Singh BB, Gautam MP, Gurung A, Chand MB, Shrestha BM.Field trial of the Penlon Manley Multivent and the DeVilbiss oxygen concentrator. World Anaesthesia Newsletter 1995; 14: 4-5. ![]()
e Dobson MB. Oxygen concentrator for the smaller hospital - a review. Tropical Doctor, April 1992. ![]()
f Roberts CW. Synthetic zeolite molecular sieves. Reprinted from Specialty Chemicals Production Marketing and Applications, February 1981. ![]()
Revision received September 17, 2001. Accepted for publication July 30, 2001.
| References |
|---|
|
|
|---|
2 Shrestha BM, Tweed WA, Basnyat NB, Lekhak BD. A modification of the Bain system for ambient air-oxygen inhalation. Anaesthesia 1994; 49: 7036.[Medline]
3
Friesen RM, Raber MB, Reimer DH. Oxygen concentrators: a primary oxygen supply source. Can J Anesth 1999; 46: 118590.
4 Fenton PM. The Malawi anaesthetic machine. Experience with a new type of anaesthetic apparatus for developing countries. Anaesthesia 1989; 44: 498503.[Medline]
5
Pedersen J, Nyrop M. Anaesthetic equipment for a developing country. Br J Anaesth 1991; 66: 26470.
6
Jarvis DA, Brock-Utne JG. Use of an oxygen concentrator linked to a draw-over vaporizer (anaesthesia delivery system for underdeveloped nations). Anesth Analg 1991; 72: 80510.
7 Friesen RM. Oxygen concentrators and the practice of anaesthesia. Can J Anaesth 1992; 39: R804.
This article has been cited by other articles:
![]() |
G. M. Reisfield and G. R. Wilson The cost of breathing: An economic analysis of the patient cost of home oxygen therapy American Journal of Hospice and Palliative Medicine, September 1, 2004; 21(5): 348 - 352. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |